Disc Medicine - Best comparison stock to Clinuvel, page-163

Yeah it's a shame, but not a huge worry for me, sooner or later Clinuvel will shine. The good thing about Clinuvel is that unlike many other companies, it can afford to remain at depressed prices for many years. They can self-finance everything in the pipeline, they won't ever need to raise capital. They will continue to add cash to the cash pile, perhaps even buy back more shares, and the valuation will simply get even more appealing at current prices. It is then perhaps not surprising that they themselves don't care so much about the share price, but I am quite confident that sooner or later Wolgen will want to turn his $50 million investment in this company into a $1 billion investment